Eszopiclone 3mg is a prescription medication used to treat insomnia [1]. It belongs to a class of drugs known as sedative-hypnotics [1].
How does eszopiclone 3mg work?
Eszopiclone functions by enhancing the effect of a neurotransmitter in the brain called GABA (gamma-aminobutyric acid) [1]. GABA slows down brain activity, which helps to induce sleep [1].
What is eszopiclone 3mg prescribed for?
This medication is prescribed to help individuals fall asleep and stay asleep [1].
What are the potential side effects of eszopiclone 3mg?
Common side effects can include an unpleasant taste, dry mouth, headache, and drowsiness [1]. More serious side effects, though less common, may involve changes in behavior, memory problems, or signs of an allergic reaction [1].
What is the typical dosage for eszopiclone 3mg?
The usual starting dose for adults is 1mg taken immediately before bedtime [1]. For some individuals, a 2mg or 3mg dose may be prescribed by a healthcare provider [1]. It is crucial to take eszopiclone exactly as directed by a doctor and not to exceed the prescribed dose [1].
Are there alternatives to eszopiclone 3mg for insomnia?
Yes, other medications are available for insomnia, including other prescription drugs, over-the-counter options, and non-pharmacological approaches like cognitive behavioral therapy for insomnia (CBT-I) [2].
What is the patent status of eszopiclone?
Eszopiclone is available as a generic medication [3]. This means that patents protecting the original brand-name drug have expired, allowing other companies to manufacture and sell their own versions [3]. Information on specific patent expirations for eszopiclone can be found on resources like DrugPatentWatch.com [3].
Who manufactures eszopiclone?
As eszopiclone is a generic drug, multiple pharmaceutical companies produce and distribute it under various brand names and as generics [3].
What are the risks associated with eszopiclone 3mg?
Potential risks include dependency, withdrawal symptoms if stopped abruptly, and a risk of complex sleep behaviors, such as sleepwalking or sleep-driving, for which the individual has no memory [1]. It can also cause next-day drowsiness, impairing activities like driving or operating machinery [1].
When does the exclusivity for eszopiclone end?
Since eszopiclone is available generically, its primary market exclusivity has already ended [3].
Sources:
[1] https://www.nhs.uk/medicines/eszopiclone/
[2] https://www.sleepfoundation.org/insomnia/treatments
[3] https://drugpatentwatch.com/